European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Clinical Application for Metabolic Profiling

Objectif

Europe faces a diabetes epidemic. More than 55 million people in Europe are currently diagnosed with diabetes and with an estimated 20% increase by 2030, the disease is certain to stay one of the most challenging health problems this century. Especially as diabetes no longer is a disease exclusively for adults, but affects children, young people and adults of all ages. Despite the high prevalence of diabetes, the choice of anti-diabetic drugs is still limited and two thirds of patients with diabetes do not achieve the recommended glycaemic target levels. For each new anti-diabetic drug, it is essential to investigate the metabolic effect over time. The glucose clamp technique is regarded as the gold standard to evaluate the effectiveness of new anti-diabetic drugs. There are however only a few centers with limited research capacities that have experience in using the clamp technique, because automated clamp devices are no longer commercially available and the existing techniques are confounded by a number of limitations. Increased clamp capacities are urgently needed for the development of new, more efficacious anti-diabetic drugs. Through the integration of newly emerging technologies proposed in part by the 4 participating SME organisations and with the outsourced research capacity of 3 of Europe’s leading RTD performers, the EU-CLAMP project aims to develop a new generation automated clamp device that will overcome the limitations of the existing devices by incorporating microdialysis technique for reliable continuous glucose monitoring without blood loss. The EU-CLAMP project will facilitate clamp testing in a more efficient and cost effective manner. In addition to the significant contribution that will be made to development of improved treatment options for diabetes, the project will provide a platform from which the competitiveness of the participating SMEs can be improved offering alignment to the needs of their long term business strategies.

Appel à propositions

FP7-SME-2010-1
Voir d’autres projets de cet appel

Régime de financement

BSG-SME - Research for SMEs

Coordinateur

PROFIL INSTITUT FUR STOFFWECHSELFORSCHUNG GMBH
Contribution de l’UE
€ 249 724,00
Adresse
HELLERSBERGSTRASSE 9
41460 Neuss
Allemagne

Voir sur la carte

Région
Nordrhein-Westfalen Düsseldorf Rhein-Kreis Neuss
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif
Tim Heise (Dr.)
Liens
Coût total
Aucune donnée

Participants (6)